CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Amlodipine besylate/ atorvastatin calcium

Last Updated: December 15, 2005
Result type: Reports
Project Number: SR0048-000
Product Line: Reimbursement Review

Generic Name: Amlodipine besylate/ atorvastatin calcium

Brand Name: Caduet

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: Hypertension/ Dyslipidemia

Indications: Hypertension/ Dyslipidemia

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 17, 2006

Recommendation Type: List with clinical criteria and/or conditions